Cached score snapshot

US.RVTY · Revvity

110分制 46/110；5D動能v2 7/50；排序分 53/160

Back to ranking Open volume snapshot

Ranking score 53/160

Main score 46/110

5D momentum v2 7/50

Rank #356

Setup grade F 22.5

Score breakdown

避免

Elevated twelvedata

Score and price trend

F 22.5 Elevated risk

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

**Historical projection**
Model	Median	P25/P75	歷史相似情境上漲比例	Down5	Actual / compare
Rolling DOE best · score 2.297 · anchors 120	+1.02%	-1.19% / +3.94%	59.7%	3.4%	Actual +2.63% · vs median +1.61% · inside 25-75 band
30D observation	+5.92%	-0.71% / +12.66%	73.4%	14.4%	Actual outcome pending · 1 / 30 bars observed
Historical projection 10D n=160	+1.00%	-1.16% / +4.40%	61.3%	1.9%	Actual outcome pending · 1 / 10 bars observed

歷史情境統計基於已存檔相似 setup；圖中投影中位線為統計中位數的線性插值展示，並非價格路徑預測或買賣建議。

2026-04-29 → 2026-09-04 · 293 archived points · 1 Improving turn signal · 5 Deteriorating signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 53

Display grade 避免

Model version cursor_18_27_news_v2_160

Main score 46/110 (避免)

5D momentum v2 7/50 (弱)

Score with momentum v2 53/160 (低排序)

Risk level Elevated

Audit trace

Full calculation detail

Calculation detail · 8 sections

Market inputs

Bar count 60

ma20 111.417

ma50 104.3782

close 110.47

prevClose 113.17

avgVolume20 1436520

volumeRatio 0.78

changePercent -2.39

Metrics snapshot

close 110.47

volume 1117800

changePercent -2.39

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 46/110

Main rating 避免

5D momentum v2 7/50

Score with momentum v2 53/160

Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 2.4/5 · 較差

Dimension score 2.4/5

Dimension grade 較差

Sub-items

pbPoints 0.5

pePoints 0.2

epsPoints 0

roePoints 0

debtPoints 0.5

marginPoints 0

turnoverUsdM 123.4834

volumePoints 0.5

revenuePoints 0

dividendPoints 0.3

marketCapPoints 0.4

資金流 — 9.2/20 · 較差

Dimension score 9.2/20

Dimension grade 較差

Sub-items

cmfPoints 0.8

mfiPoints 1.6

obvPoints 4

vwapPoints 0.8

institutional

score 2

details

source optional-neutral

warning

code INSTITUTIONAL_DATA_OPTIONAL

symbol US.RVTY

message Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.

optional true

holderCount n/a

holderPoints 2

top10ShareRatio n/a

concentrationPenalty 0

institutionPoints 2

市場環境 — 7/15 · 較差

Dimension score 7/15

Dimension grade 較差

Sub-items

vix

score 1.8

details

source twelvedata+fred

vixClose 18.7

trend

score 0.8

details

qqq

ma20 711.713

ma50 718.2872

name QQQ

close 684.23

points 0.4

spy

ma20 746.153

ma50 745.068

name SPY

close 738.93

points 0.4

source twelvedata+fred

atrPct 3.2711

atrPoints 2

cciPoints 2.4

vixPoints 1.8

marketTrendPoints 0.8

催化劑 — 2/20 · 較差

Dimension score 2/20

Dimension grade 較差

Sub-items

catalyst

score 2

details

source finnhub_news_keyword_model

articleCount 3

catalystCount 0

catalystPoints 2

風險管理 — 6.3/10 · 一般

Dimension score 6.3/10

Dimension grade 一般

Sub-items

position

score 1.1

details

atrPct 3.2711

turnoverUsdM 123.4834

liquidityPoints 0.4

volatilityPoints 0.7

rrPoints 1.4

stopLevels

symbol US.RVTY

rr_range 1:1.0-1:2.5

risk_profile 中等

stop_loss_price 103.2428

strength_details

ma_score 1.5

atr_score 1

rsi_score 1

macd_score 1.5

volume_score 1

market_adjustment 1

risk_reward_ratio 1

stop_loss_percent 6.5

take_profit_price 115.9935

target_multiplier 1.6

technical_strength 1.22

take_profit_percent 5

positionPoints 1.1

stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used

sector Health Care

concentratedSectorPenalty 0

riskRewardRatio 1.2

stopLossPercent 6.5422

diversificationPoints 2

技術信號 — 17.1/30 · 較差

Dimension score 17.1/30

Dimension grade 較差

Sub-items

bbPoints 2.4

adxPoints 3

sarPoints 1.2

vcpPoints 1.5

macdPoints 2.4

vcpPayload

vcp_pass false

vcp_score 1.5

vcp_reason 跌縮量(近10日3日)；站上MA50；升放量(近10日3日)；Ready=N；Confirm=N

vcp_metrics

up_days 6

vol_ref 1429750

down_days 3

vcp_ready false

above_ma50 true

avg_vol_10 1229850

avg_vol_20 1490260

avg_vol_30 1429750

range_pct_10 0.1234

range_pct_20 0.1248

range_pct_30 0.1747

up_expand_ok true

lookback_used 59

near_20d_high true

contraction_ok false

down_shrink_ok true

up_expand_days 3

breakout_20d_ok false

vol_ratio_10_30 0.8602

dist_to_20d_high 0.049

down_shrink_days 3

breakout_level_20d 116.16

vcp_breakout_confirm false

contraction_ratio_10_30 0.7062

vcp_name_en Volatility Contraction Pattern

vcp_name_zh 波動收縮形態

vol_contraction false

kdjAdxPoints 0.8

rsiKdjPoints 2.4

volumeWeight 2

maCrossPoints 1.6

shortRsiPoints 0.4

shortMacdPoints 0.4

volConfirmPoints 0.6

volumePointsTechnical 0.4

情緒分析 — 2/10 · 較差

Dimension score 2/10

Dimension grade 較差

Sub-items

sentiment

score 2

details

source finnhub_news_keyword_model

articleCount 3

negativeHits 0

positiveHits 0

sentimentScoreRaw 0

sentimentData

raw {"id":140857306,"url":"https://finnhub.io/api/news?id=2e743ed2bd742fc2927d46f5409e758b51daa3e56f552b322b5d166be84549f5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"In early July 2026, Anthropic announced that Revvity Signals Software joined its Model Context Protocol connector directory, allowing scientists to access Signals AI and connected R&D knowledge directly through Claude, including the Claude Science workbench. This move links Claude’s reasoning tools with Revvity’s governed, ontology-driven scientific data, potentially making AI-driven discovery workflows more accessible to life sciences researchers who already rely on Revvity’s Signals...","category":"company","datetime":1783642634,"headline":"Should Revvity’s (RVTY) Claude Integration Reframe How Investors View Its Data and AI Strategy?"}, {"id":140851144,"url":"https://finnhub.io/api/news?id=ed9cd6f320fc89c6a5e7bcc42dca439e032e42e1027c5e5b327cc7e3835ff360","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"Revvity's (NYSE:RVTY) Signals Software platform has joined Anthropic's Model Context Protocol directory. The move connects Signals AI to Anthropic's Claude models, aiming to streamline scientific data access and analysis. This development is positioned to expand how researchers interact with complex R&D datasets using AI tools. For investors watching Revvity, this news sits at the intersection of lab software and advanced AI. The company is already active in scientific research tools, and...","category":"company","datetime":1783603104,"headline":"Revvity (RVTY) Joins Anthropic Directory To Bring Claude Into Signals Research Workflows"}, {"id":140793225,"url":"https://finnhub.io/api/news?id=c1b7af8a578f532a7a93cabdad54a8c102dfa0a3d46d0f47c170f6cef4aa7533","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"Revvity’s 14.9% return over the past six months has outpaced the S&P 500 by 5.6%, and its stock price has climbed to $112.79 per share. This performance may have investors wondering how to approach the situation.","category":"company","datetime":1783011144,"headline":"3 Reasons to Avoid RVTY and 1 Stock to Buy Instead"}

raw_source {"id":141007921,"url":"https://finnhub.io/api/news?id=81d9e34fdfd7a95dd140c3b55594eacb4f418e518b7d324ee8d3ea4ef365f1e6","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"RVTY's T-SPOT A201 targets a 2027 launch, promising high-throughput latent TB testing with greater lab efficiency and scalability.","category":"company","datetime":1784905500,"headline":"Revvity Develops High-Throughput T-SPOT.TB Platform for Clinical Labs"}, {"id":140984920,"url":"https://finnhub.io/api/news?id=baf18e37cd128514c37b8ec0c38c1918eac8f805b29c5b540d025957786c2803","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"RVTY's Signals for Startups gives early-stage biotechs scalable software and guided onboarding to streamline research and support future growth.","category":"company","datetime":1784732640,"headline":"Revvity to Launch Signals for Startups for Emerging Biotech Companies"}, {"id":140961419,"url":"https://finnhub.io/api/news?id=d637934a79a18f0fbb5960f741f6b23332bad7d4c8cea1f1b5a337a6b4684e21","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"RVTY","summary":"Stay updated with the movements of the S&P500 index in the middle of the day on Monday. Discover which stocks are leading as top gainers and losers in today's session.","category":"company","datetime":1784565301,"headline":"What's going on in today's session: S&P500 movers"}, {"id":140959733,"url":"https://finnhub.io/api/news?id=ec2c8b4aa9ec3fcd3fa66881efa640085641940c35c085e53f90a3c1d31f7465","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"WALTHAM, Mass., July 20, 2026--Revvity, Inc. (NYSE: RVTY) today published its 2026 Impact Report, highlighting the Company’s sustainability, social and governance strategy, initiatives and performance. The annual report showcases how the Company continues to translate innovation into real-world impact, while embedding responsible and sustainable practices through its operations.","category":"company","datetime":1784548800,"headline":"Revvity Releases 2026 Impact Report Advancing Transparency with Initial Scope 3 Emissions Disclosure"}, {"id":140959732,"url":"https://finnhub.io/api/news?id=62554a7a0acbc3a8a57c0e3f57f01312083c4125e881573cbb3c57051ffeec92","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"WALTHAM, Mass., July 20, 2026--Revvity, Inc. announced that its Revvity Signals Software business is launching Signals for Startups, a new program designed to help emerging biotechnology companies adopt scalable informatics capabilities earlier in their growth journey. Built for early-stage biotechs, the program combines access to enterprise-grade Signals software with guided onboarding and best-practice configurations tailored specifically for smaller biotechs to help accelerate innovation, imp","category":"company","datetime":1784548800,"headline":"Revvity Launches \"Signals for Startups\" to Help Emerging Biotechs Build Scalable Digital Foundations from Day One"}, {"id":140891351,"url":"https://finnhub.io/api/news?id=e241c1ffe64c739ef93aa279e16d8b927df3ed6bdc10741dd02d51309b8e4eef","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"If you’re an Alamar Biosciences (ALMR) shareholder, Friday was a good day. The stock climbed +7.3%, closing the session at a new 52-week high of $28.42. That’s a tidy gain on a day when the S&P 500 barely nudged up +0.4% and some key industry peers actually lost ground.","category":"company","datetime":1783975817,"headline":"Alamar Hits A High Note On Alzheimer's Buzz"}, {"id":140887702,"url":"https://finnhub.io/api/news?id=050b0b02568f7c68c8f52f211f79b9a667979105cfa50ec47bf4b9674c2df61e","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/849207670/image_849207670.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"RVTY","summary":"Revvity, Inc. trades near 52-week highs, buoyed by sector M&A momentum but faces fundamental headwinds. Learn more about RVTY stock now.","category":"company","datetime":1783946460,"headline":"Revvity: Overvalued On Sentiment"}, {"id":140857306,"url":"https://finnhub.io/api/news?id=2e743ed2bd742fc2927d46f5409e758b51daa3e56f552b322b5d166be84549f5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"In early July 2026, Anthropic announced that Revvity Signals Software joined its Model Context Protocol connector directory, allowing scientists to access Signals AI and connected R&D knowledge directly through Claude, including the Claude Science workbench. This move links Claude’s reasoning tools with Revvity’s governed, ontology-driven scientific data, potentially making AI-driven discovery workflows more accessible to life sciences researchers who already rely on Revvity’s Signals...","category":"company","datetime":1783642634,"headline":"Should Revvity’s (RVTY) Claude Integration Reframe How Investors View Its Data and AI Strategy?"}, {"id":140851144,"url":"https://finnhub.io/api/news?id=ed9cd6f320fc89c6a5e7bcc42dca439e032e42e1027c5e5b327cc7e3835ff360","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"Revvity's (NYSE:RVTY) Signals Software platform has joined Anthropic's Model Context Protocol directory. The move connects Signals AI to Anthropic's Claude models, aiming to streamline scientific data access and analysis. This development is positioned to expand how researchers interact with complex R&D datasets using AI tools. For investors watching Revvity, this news sits at the intersection of lab software and advanced AI. The company is already active in scientific research tools, and...","category":"company","datetime":1783603104,"headline":"Revvity (RVTY) Joins Anthropic Directory To Bring Claude Into Signals Research Workflows"}, {"id":140850105,"url":"https://finnhub.io/api/news?id=ce0913844bbfe462e69b9fb5cc1739fbf15ce70eb94ca1ed4fb38cc13cb73b83","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 10% over the past six months, topping the S&P 500 by 2.3 percentage points.","category":"company","datetime":1783597740,"headline":"3 Healthcare Stocks We Think Twice About"}, {"id":140840743,"url":"https://finnhub.io/api/news?id=6aae3e868a130dede5f106332f906bff51cb68f49e6f8b5b73e9297d45e76796","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"WALTHAM, Mass., July 08, 2026--Revvity, Inc. (NYSE: RVTY), today announced that it will release its second quarter 2026 financial results prior to market open on Tuesday, August 4, 2026. The Company will host a conference call the same day at 7:30 a.m. ET to discuss these results. Prahlad Singh, president and chief executive officer, and Max Krakowiak, chief financial officer, will host the conference call.","category":"company","datetime":1783512000,"headline":"Revvity to Hold Earnings Call on Tuesday, August 4, 2026"}, {"id":140824918,"url":"https://finnhub.io/api/news?id=6e3758af8903e45d471398a3e7de8bd2d18328fbb3599c9dfea213d5967bcb98","image":"","source":"Benzinga","related":"RVTY","summary":"Evercore ISI Group analyst Vijay Kumar maintains Revvity (NYSE:RVTY) with a Outperform and raises the price target from $110 to $125.","category":"company","datetime":1783342610,"headline":"Evercore ISI Group Maintains Outperform on Revvity, Raises Price Target to $125"}, {"id":140801341,"url":"https://finnhub.io/api/news?id=f9bcad11b29e77603e5b01c6c9ff27ba8e5124c642a3d3c498233281a80c48d6","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"As Revvity gears up to reveal its second-quarter earnings report soon, analysts forecast single-digit profit growth.","category":"company","datetime":1783077161,"headline":"What You Need to Know Ahead of Revvity’s Earnings Release"}, {"id":140793225,"url":"https://finnhub.io/api/news?id=c1b7af8a578f532a7a93cabdad54a8c102dfa0a3d46d0f47c170f6cef4aa7533","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"Revvity’s 14.9% return over the past six months has outpaced the S&P 500 by 5.6%, and its stock price has climbed to $112.79 per share. This performance may have investors wondering how to approach the situation.","category":"company","datetime":1783011144,"headline":"3 Reasons to Avoid RVTY and 1 Stock to Buy Instead"}, {"id":140791605,"url":"https://finnhub.io/api/news?id=fd38a14f1a1829541fca1dfca16f077cbcaa7f3b4dfd12a73f8a353bd04ebe5d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"RVTY expands Signals AI through Anthropic's MCP ecosystem, giving scientists secure Claude access to connected R&D data and scientific context.","category":"company","datetime":1783000620,"headline":"Revvity Expands Signals AI With Anthropic Claude Integration"}, {"id":140778935,"url":"https://finnhub.io/api/news?id=a019e01d5cd49fe07970675558c93d3084461af974774ec0b32e2180604d3506","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"RVTY","summary":"WALTHAM, Mass., July 01, 2026--Revvity, Inc. (NYSE: RVTY) announced that its Revvity Signals Software business has joined Anthropic's directory for Model Context Protocol (MCP) connectors, enabling scientists to access Signals AI capabilities and connected R&D knowledge through Claude, including Claude Science, Anthropic’s new AI workbench for scientific research.","category":"company","datetime":1782907200,"headline":"Revvity Expands Signals AI Ecosystem Through Anthropic Claude Integration"}, {"id":140739738,"url":"https://finnhub.io/api/news?id=8e2a0a9922273da83d137eddceea284b0ff431d273ce8087e05d0f1e847d9d7c","image":"","source":"Benzinga","related":"RVTY","summary":"Bernstein analyst Eve Burstein reinstates Revvity (NYSE:RVTY) with a Market Perform and announces $115 price target.","category":"company","datetime":1782465484,"headline":"Bernstein Reinstates Market Perform on Revvity, Announces $115 Price Target"}

data_source finnhub_news_keyword_model

article_count 3

negative_hits 0

positive_hits 0

recomputed_at_score true

sentiment_score_raw 0

source_article_count 17

discarded_article_count 14

sentimentPoints 2

Dimension contribution

Dimension Raw Max Norm % Contrib

基本面 2.4 5/110 48% 2.4

資金流 9.2 20/110 46% 9.2

市場環境 7 15/110 46.67% 7

催化劑 2 20/110 10% 2

風險管理 6.3 10/110 63% 6.3

技術信號 17.1 30/110 57% 17.1

情緒分析 2 10/110 20% 2

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 7/50

ret_5d 0.0029

max_score 50

max_total 50

raw_total 7

vcp_bonus 0

vol_ratio 0.7501

ret_points 4

vol_points 0

range_ratio 0.9742

volat_points 0

day_range_pct 0.0322

model_version cursor_18_27_news_v2_160

available_bars 30

breakout_points 0

partial_history false

pullback_points 3

breakout_vol_bonus 0

first_breakout_20d false

return_window_days 5

first_breakout_bonus 0

breakout_quality_points 0

Risk management

level Elevated

reason risk management score >= 5/10

position

score 1.1

details

atrPct 3.2711

turnoverUsdM 123.4834

liquidityPoints 0.4

volatilityPoints 0.7

rrPoints 1.4

stopLevels

symbol US.RVTY

rr_range 1:1.0-1:2.5

risk_profile 中等

stop_loss_price 103.2428

strength_details

ma_score 1.5

atr_score 1

rsi_score 1

macd_score 1.5

volume_score 1

market_adjustment 1

risk_reward_ratio 1

stop_loss_percent 6.5

take_profit_price 115.9935

target_multiplier 1.6

technical_strength 1.22

take_profit_percent 5

positionPoints 1.1

stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used

sector Health Care

concentratedSectorPenalty 0

riskRewardRatio 1.2

stopLossPercent 6.5422

diversificationPoints 2

Calculation audit log

基本面分析總分: 2.4/5分
資金流分析總分: 9.2/20分
市場環境分析總分: 7/15分
催化劑分析: 2/20分
風險管理總分: 6.3/10分
技術信號分析總分: 17.1/30分
情緒分析: 2/10分
共振率(僅顯示不加分): 0%

Technical indicators

adx

value 92.86

atr

atr 3.6136

rule ATR / current price; lower volatility scores higher

score 4

atr_pct 3.27

cci

rule Cursor_18.24 CCI bands

level 平衡

score 6

value 5.1

cmf

rule Cursor_18.24 CMF bands

level 派發

score 2

value -0.0555

kdj

d 55.42

j 72.12

k 60.98

rule Cursor_18.24 K/D cross

score 6

signal 強金叉

mfi

rule Cursor_18.24 MFI bands

level 弱流入

score 4

value 48.15

obv

rule Cursor_18.24 recent_slope vs previous_slope

score 10

trend 強流入

value 17670600

recentSlope 412970

previousSlope -67470

rsi

value 44.9

sar

rule Cursor_18.24 Parabolic SAR

score 4

trend 下降

value 114.3944

position SAR喺價上

distancePct 3.55

previousTrend 下降

ma50

value 104.3782

macd

macd 1.8687

trend 中性偏多

signal 2.421

histogram -0.5524

vwap

rule Cursor_18.24 VWAP 20D consecutive close

score 2

value 111.5962

position <VWAP

consecutiveAbove 0

volume

rule Cursor_18.24 volume ratio

level 空升

ratio 0.78

score 2

avgVolume 1436520

currentVolume 1117800

derived

ma20 111.417

ma50 104.3782

prevClose 113.17

avgVolume10 1248710

avgVolume20 1436520

changePercent -2.39

avgVolumeForScore 1436520

ma_cross

ma20 111.417

ma50 104.3782

rule Cursor_18.24 MA20/MA50 cross

cross 多頭

score 4

prevMa20 111.57

prevMa50 104.1548

spreadPct 6.74

isVolumeBreakout false

bollinger

lower 108.1788

upper 114.6552

position 中間

rsi_short

value 45.81

macd_short

macd 0

trend 中性

signal 0

histogram 0

volume_ratio

ratio 0.78

Raw calculation JSON

{
  "risk": {
    "level": "Elevated",
    "reason": "risk management score >= 5/10",
    "position": {
      "score": 1.1,
      "details": {
        "atrPct": 3.2711143296822667,
        "turnoverUsdM": 123.483366,
        "liquidityPoints": 0.4,
        "volatilityPoints": 0.7
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.RVTY",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 103.2428,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 1,
        "rsi_score": 1,
        "macd_score": 1.5,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 6.5,
      "take_profit_price": 115.9935,
      "target_multiplier": 1.6,
      "technical_strength": 1.22,
      "take_profit_percent": 5
    },
    "positionPoints": 1.1,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 6.542228659364533,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 53,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 46,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 7
  },
  "market": {
    "ma20": 111.417,
    "ma50": 104.3782,
    "close": 110.47,
    "prevClose": 113.17,
    "avgVolume20": 1436520,
    "volumeRatio": 0.78,
    "changePercent": -2.39
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 7,
    "details": {
      "ret_5d": 0.002905129369042081,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 7,
      "vcp_bonus": 0,
      "vol_ratio": 0.7500704575040597,
      "ret_points": 4,
      "vol_points": 0,
      "range_ratio": 0.974197530812703,
      "volat_points": 0,
      "day_range_pct": 0.03222594369512087,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 3,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 53,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.4,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 48,
        "contribution": 2.4
      },
      {
        "raw": 9.2,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 46,
        "contribution": 9.2
      },
      {
        "raw": 7,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 46.67,
        "contribution": 7
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 6.3,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 63,
        "contribution": 6.3
      },
      {
        "raw": 17.1,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 57,
        "contribution": 17.1
      },
      {
        "raw": 2,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 20,
        "contribution": 2
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "避免",
    "result": 46,
    "details": [
      "基本面分析總分: 2.4/5分",
      "資金流分析總分: 9.2/20分",
      "市場環境分析總分: 7/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 6.3/10分",
      "技術信號分析總分: 17.1/30分",
      "情緒分析: 2/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 2.4,
      "資金流": 9.2,
      "市場環境": 7,
      "情緒分析": 2,
      "技術信號": 17.1,
      "風險管理": 6.3
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 3,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0.5,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0,
          "debtPoints": 0.5,
          "marginPoints": 0,
          "turnoverUsdM": 123.483366,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.4
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 1.6,
          "obvPoints": 4,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.RVTY",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 1.8,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 18.7
            }
          },
          "trend": {
            "score": 0.8,
            "details": {
              "qqq": {
                "ma20": 711.71300025,
                "ma50": 718.2872022,
                "name": "QQQ",
                "close": 684.22998,
                "points": 0.4
              },
              "spy": {
                "ma20": 746.1530053500001,
                "ma50": 745.0680014400001,
                "name": "SPY",
                "close": 738.92999,
                "points": 0.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 3.2711143296822667,
          "atrPoints": 2,
          "cciPoints": 2.4,
          "vixPoints": 1.8,
          "marketTrendPoints": 0.8
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 3,
              "negativeHits": 0,
              "positiveHits": 0,
              "sentimentScoreRaw": 0
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 140857306,
                "url": "https://finnhub.io/api/news?id=2e743ed2bd742fc2927d46f5409e758b51daa3e56f552b322b5d166be84549f5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "In early July 2026, Anthropic announced that Revvity Signals Software joined its Model Context Protocol connector directory, allowing scientists to access Signals AI and connected R&D knowledge directly through Claude, including the Claude Science workbench. This move links Claude’s reasoning tools with Revvity’s governed, ontology-driven scientific data, potentially making AI-driven discovery workflows more accessible to life sciences researchers who already rely on Revvity’s Signals...",
                "category": "company",
                "datetime": 1783642634,
                "headline": "Should Revvity’s (RVTY) Claude Integration Reframe How Investors View Its Data and AI Strategy?"
              },
              {
                "id": 140851144,
                "url": "https://finnhub.io/api/news?id=ed9cd6f320fc89c6a5e7bcc42dca439e032e42e1027c5e5b327cc7e3835ff360",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Revvity's (NYSE:RVTY) Signals Software platform has joined Anthropic's Model Context Protocol directory. The move connects Signals AI to Anthropic's Claude models, aiming to streamline scientific data access and analysis. This development is positioned to expand how researchers interact with complex R&D datasets using AI tools. For investors watching Revvity, this news sits at the intersection of lab software and advanced AI. The company is already active in scientific research tools, and...",
                "category": "company",
                "datetime": 1783603104,
                "headline": "Revvity (RVTY) Joins Anthropic Directory To Bring Claude Into Signals Research Workflows"
              },
              {
                "id": 140793225,
                "url": "https://finnhub.io/api/news?id=c1b7af8a578f532a7a93cabdad54a8c102dfa0a3d46d0f47c170f6cef4aa7533",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Revvity’s 14.9% return over the past six months has outpaced the S&P 500 by 5.6%, and its stock price has climbed to $112.79 per share. This performance may have investors wondering how to approach the situation.",
                "category": "company",
                "datetime": 1783011144,
                "headline": "3 Reasons to Avoid RVTY and 1 Stock to Buy Instead"
              }
            ],
            "raw_source": [
              {
                "id": 141007921,
                "url": "https://finnhub.io/api/news?id=81d9e34fdfd7a95dd140c3b55594eacb4f418e518b7d324ee8d3ea4ef365f1e6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "RVTY's T-SPOT A201 targets a 2027 launch, promising high-throughput latent TB testing with greater lab efficiency and scalability.",
                "category": "company",
                "datetime": 1784905500,
                "headline": "Revvity Develops High-Throughput T-SPOT.TB Platform for Clinical Labs"
              },
              {
                "id": 140984920,
                "url": "https://finnhub.io/api/news?id=baf18e37cd128514c37b8ec0c38c1918eac8f805b29c5b540d025957786c2803",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "RVTY's Signals for Startups gives early-stage biotechs scalable software and guided onboarding to streamline research and support future growth.",
                "category": "company",
                "datetime": 1784732640,
                "headline": "Revvity to Launch Signals for Startups for Emerging Biotech Companies"
              },
              {
                "id": 140961419,
                "url": "https://finnhub.io/api/news?id=d637934a79a18f0fbb5960f741f6b23332bad7d4c8cea1f1b5a337a6b4684e21",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "RVTY",
                "summary": "Stay updated with the movements of the S&P500 index in the middle of the day on Monday. Discover which stocks are leading as top gainers and losers in today's session.",
                "category": "company",
                "datetime": 1784565301,
                "headline": "What's going on in today's session: S&P500 movers"
              },
              {
                "id": 140959733,
                "url": "https://finnhub.io/api/news?id=ec2c8b4aa9ec3fcd3fa66881efa640085641940c35c085e53f90a3c1d31f7465",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "WALTHAM, Mass., July 20, 2026--Revvity, Inc. (NYSE: RVTY) today published its 2026 Impact Report, highlighting the Company’s sustainability, social and governance strategy, initiatives and performance. The annual report showcases how the Company continues to translate innovation into real-world impact, while embedding responsible and sustainable practices through its operations.",
                "category": "company",
                "datetime": 1784548800,
                "headline": "Revvity Releases 2026 Impact Report Advancing Transparency with Initial Scope 3 Emissions Disclosure"
              },
              {
                "id": 140959732,
                "url": "https://finnhub.io/api/news?id=62554a7a0acbc3a8a57c0e3f57f01312083c4125e881573cbb3c57051ffeec92",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "WALTHAM, Mass., July 20, 2026--Revvity, Inc. announced that its Revvity Signals Software business is launching Signals for Startups, a new program designed to help emerging biotechnology companies adopt scalable informatics capabilities earlier in their growth journey. Built for early-stage biotechs, the program combines access to enterprise-grade Signals software with guided onboarding and best-practice configurations tailored specifically for smaller biotechs to help accelerate innovation, imp",
                "category": "company",
                "datetime": 1784548800,
                "headline": "Revvity Launches \"Signals for Startups\" to Help Emerging Biotechs Build Scalable Digital Foundations from Day One"
              },
              {
                "id": 140891351,
                "url": "https://finnhub.io/api/news?id=e241c1ffe64c739ef93aa279e16d8b927df3ed6bdc10741dd02d51309b8e4eef",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "If you’re an Alamar Biosciences (ALMR) shareholder, Friday was a good day. The stock climbed +7.3%, closing the session at a new 52-week high of $28.42. That’s a tidy gain on a day when the S&P 500 barely nudged up +0.4% and some key industry peers actually lost ground.",
                "category": "company",
                "datetime": 1783975817,
                "headline": "Alamar Hits A High Note On Alzheimer's Buzz"
              },
              {
                "id": 140887702,
                "url": "https://finnhub.io/api/news?id=050b0b02568f7c68c8f52f211f79b9a667979105cfa50ec47bf4b9674c2df61e",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/849207670/image_849207670.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "RVTY",
                "summary": "Revvity, Inc. trades near 52-week highs, buoyed by sector M&A momentum but faces fundamental headwinds. Learn more about RVTY stock now.",
                "category": "company",
                "datetime": 1783946460,
                "headline": "Revvity: Overvalued On Sentiment"
              },
              {
                "id": 140857306,
                "url": "https://finnhub.io/api/news?id=2e743ed2bd742fc2927d46f5409e758b51daa3e56f552b322b5d166be84549f5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "In early July 2026, Anthropic announced that Revvity Signals Software joined its Model Context Protocol connector directory, allowing scientists to access Signals AI and connected R&D knowledge directly through Claude, including the Claude Science workbench. This move links Claude’s reasoning tools with Revvity’s governed, ontology-driven scientific data, potentially making AI-driven discovery workflows more accessible to life sciences researchers who already rely on Revvity’s Signals...",
                "category": "company",
                "datetime": 1783642634,
                "headline": "Should Revvity’s (RVTY) Claude Integration Reframe How Investors View Its Data and AI Strategy?"
              },
              {
                "id": 140851144,
                "url": "https://finnhub.io/api/news?id=ed9cd6f320fc89c6a5e7bcc42dca439e032e42e1027c5e5b327cc7e3835ff360",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Revvity's (NYSE:RVTY) Signals Software platform has joined Anthropic's Model Context Protocol directory. The move connects Signals AI to Anthropic's Claude models, aiming to streamline scientific data access and analysis. This development is positioned to expand how researchers interact with complex R&D datasets using AI tools. For investors watching Revvity, this news sits at the intersection of lab software and advanced AI. The company is already active in scientific research tools, and...",
                "category": "company",
                "datetime": 1783603104,
                "headline": "Revvity (RVTY) Joins Anthropic Directory To Bring Claude Into Signals Research Workflows"
              },
              {
                "id": 140850105,
                "url": "https://finnhub.io/api/news?id=ce0913844bbfe462e69b9fb5cc1739fbf15ce70eb94ca1ed4fb38cc13cb73b83",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 10% over the past six months, topping the S&P 500 by 2.3 percentage points.",
                "category": "company",
                "datetime": 1783597740,
                "headline": "3 Healthcare Stocks We Think Twice About"
              },
              {
                "id": 140840743,
                "url": "https://finnhub.io/api/news?id=6aae3e868a130dede5f106332f906bff51cb68f49e6f8b5b73e9297d45e76796",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "WALTHAM, Mass., July 08, 2026--Revvity, Inc. (NYSE: RVTY), today announced that it will release its second quarter 2026 financial results prior to market open on Tuesday, August 4, 2026. The Company will host a conference call the same day at 7:30 a.m. ET to discuss these results. Prahlad Singh, president and chief executive officer, and Max Krakowiak, chief financial officer, will host the conference call.",
                "category": "company",
                "datetime": 1783512000,
                "headline": "Revvity to Hold Earnings Call on Tuesday, August 4, 2026"
              },
              {
                "id": 140824918,
                "url": "https://finnhub.io/api/news?id=6e3758af8903e45d471398a3e7de8bd2d18328fbb3599c9dfea213d5967bcb98",
                "image": "",
                "source": "Benzinga",
                "related": "RVTY",
                "summary": "Evercore ISI Group  analyst Vijay Kumar   maintains Revvity (NYSE:RVTY) with a Outperform and raises the price target from $110 to $125.",
                "category": "company",
                "datetime": 1783342610,
                "headline": "Evercore ISI Group Maintains Outperform on Revvity, Raises Price Target to $125"
              },
              {
                "id": 140801341,
                "url": "https://finnhub.io/api/news?id=f9bcad11b29e77603e5b01c6c9ff27ba8e5124c642a3d3c498233281a80c48d6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "As Revvity gears up to reveal its second-quarter earnings report soon, analysts forecast single-digit profit growth.",
                "category": "company",
                "datetime": 1783077161,
                "headline": "What You Need to Know Ahead of Revvity’s Earnings Release"
              },
              {
                "id": 140793225,
                "url": "https://finnhub.io/api/news?id=c1b7af8a578f532a7a93cabdad54a8c102dfa0a3d46d0f47c170f6cef4aa7533",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "Revvity’s 14.9% return over the past six months has outpaced the S&P 500 by 5.6%, and its stock price has climbed to $112.79 per share. This performance may have investors wondering how to approach the situation.",
                "category": "company",
                "datetime": 1783011144,
                "headline": "3 Reasons to Avoid RVTY and 1 Stock to Buy Instead"
              },
              {
                "id": 140791605,
                "url": "https://finnhub.io/api/news?id=fd38a14f1a1829541fca1dfca16f077cbcaa7f3b4dfd12a73f8a353bd04ebe5d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "RVTY expands Signals AI through Anthropic's MCP ecosystem, giving scientists secure Claude access to connected R&D data and scientific context.",
                "category": "company",
                "datetime": 1783000620,
                "headline": "Revvity Expands Signals AI With Anthropic Claude Integration"
              },
              {
                "id": 140778935,
                "url": "https://finnhub.io/api/news?id=a019e01d5cd49fe07970675558c93d3084461af974774ec0b32e2180604d3506",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "RVTY",
                "summary": "WALTHAM, Mass., July 01, 2026--Revvity, Inc. (NYSE: RVTY) announced that its Revvity Signals Software business has joined Anthropic's directory for Model Context Protocol (MCP) connectors, enabling scientists to access Signals AI capabilities and connected R&D knowledge through Claude, including Claude Science, Anthropic’s new AI workbench for scientific research.",
                "category": "company",
                "datetime": 1782907200,
                "headline": "Revvity Expands Signals AI Ecosystem Through Anthropic Claude Integration"
              },
              {
                "id": 140739738,
                "url": "https://finnhub.io/api/news?id=8e2a0a9922273da83d137eddceea284b0ff431d273ce8087e05d0f1e847d9d7c",
                "image": "",
                "source": "Benzinga",
                "related": "RVTY",
                "summary": "Bernstein  analyst Eve Burstein   reinstates Revvity (NYSE:RVTY) with a Market Perform and announces $115 price target.",
                "category": "company",
                "datetime": 1782465484,
                "headline": "Bernstein Reinstates Market Perform on Revvity, Announces $115 Price Target"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 3,
            "negative_hits": 0,
            "positive_hits": 0,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0,
            "source_article_count": 17,
            "discarded_article_count": 14
          },
          "sentimentPoints": 2
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 17.1,
        "grade": "較差",
        "items": {
          "bbPoints": 2.4,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 1.5,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 1.5,
            "vcp_reason": "跌縮量(近10日3日)；站上MA50；升放量(近10日3日)；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 6,
              "vol_ref": 1429750,
              "down_days": 3,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 1229850,
              "avg_vol_20": 1490260,
              "avg_vol_30": 1429750,
              "range_pct_10": 0.12338191364171264,
              "range_pct_20": 0.12483027066171805,
              "range_pct_30": 0.17470806553815513,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": true,
              "up_expand_days": 3,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.8601853470886519,
              "dist_to_20d_high": 0.04898415977961431,
              "down_shrink_days": 3,
              "breakout_level_20d": 116.16,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.7062176165803107
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.8,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0.4,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 0.4
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.1,
            "details": {
              "atrPct": 3.2711143296822667,
              "turnoverUsdM": 123.483366,
              "liquidityPoints": 0.4,
              "volatilityPoints": 0.7
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.RVTY",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 103.2428,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 1,
              "rsi_score": 1,
              "macd_score": 1.5,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 6.5,
            "take_profit_price": 115.9935,
            "target_multiplier": 1.6,
            "technical_strength": 1.22,
            "take_profit_percent": 5
          },
          "positionPoints": 1.1,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 6.542228659364533,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 92.86,
    "atr": {
      "atr": 3.6136,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 4,
      "atr_pct": 3.27
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "平衡",
      "score": 6,
      "value": 5.1
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.0555
    },
    "kdj": {
      "d": 55.42,
      "j": 72.12,
      "k": 60.98,
      "rule": "Cursor_18.24 K/D cross",
      "score": 6,
      "signal": "強金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "弱流入",
      "score": 4,
      "value": 48.15
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": 17670600,
      "recentSlope": 412970,
      "previousSlope": -67470
    },
    "rsi": 44.9,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 114.3944,
      "position": "SAR喺價上",
      "distancePct": 3.55,
      "previousTrend": "下降"
    },
    "ma50": 104.3782,
    "macd": {
      "macd": 1.868650492531927,
      "trend": "中性偏多",
      "signal": 2.421040835563257,
      "histogram": -0.55239034303133
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 111.5962,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "空升",
      "ratio": 0.78,
      "score": 2,
      "avgVolume": 1436520,
      "currentVolume": 1117800
    },
    "derived": {
      "ma20": 111.417,
      "ma50": 104.3782,
      "prevClose": 113.17,
      "avgVolume10": 1248710,
      "avgVolume20": 1436520,
      "changePercent": -2.39,
      "avgVolumeForScore": 1436520
    },
    "ma_cross": {
      "ma20": 111.417,
      "ma50": 104.3782,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 111.57,
      "prevMa50": 104.1548,
      "spreadPct": 6.74,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 108.1788,
      "upper": 114.6552,
      "position": "中間"
    },
    "rsi_short": 45.81,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.78
    }
  }
}

Raw metrics JSON

{
  "close": 110.47,
  "volume": 1117800,
  "changePercent": -2.39
}

Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.

US.RVTY · Revvity

避免

Score and price trend

Summary

Rolling setup rating

Has the score quality changed?

Signals

Full calculation detail

Market inputs

Metrics snapshot

110-point main rating

基本面 — 2.4/5 · 較差

Sub-items

資金流 — 9.2/20 · 較差

Sub-items

institutional

details

warning

市場環境 — 7/15 · 較差

Sub-items

vix

details

trend

details

qqq

spy

催化劑 — 2/20 · 較差

Sub-items

catalyst

details

風險管理 — 6.3/10 · 一般

Sub-items

position

details

stopLevels

strength_details

diversification

details

技術信號 — 17.1/30 · 較差

Sub-items

vcpPayload

vcp_metrics

情緒分析 — 2/10 · 較差

Sub-items

sentiment

details

sentimentData

Dimension contribution

5D momentum v2 breakdown

Risk management

position

details

stopLevels

strength_details

diversification

details

Calculation audit log

Technical indicators

Raw calculation JSON

Raw metrics JSON